Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

233.37
Delayed Data
As of Feb 03
 0.00 / 0.00%
Today’s Change
117.58
Today|||52-Week Range
242.97
-1.80%
Year-to-Date

Stock Price Forecast

The 23 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 252.00, with a high estimate of 415.00 and a low estimate of 143.00. The median estimate represents a +7.98% increase from the last price of 233.37.

Analyst Recommendations

The current consensus among 26 polled investment analysts is to Buy stock in Alnylam Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.85
Sales
$313.1M
Reporting Date
Feb 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 44.42%
 
 
 
 
 
 
Growthannually -23.95%
 
 
 
 
 
 

Sales

Growthquarterly 18.47%
 
 
 
 
 
 
Growthannually 20.07%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.